Havilah Resources Ltd (ASX: HAV) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Havilah Resources Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Havilah Resources Ltd (ASX: HAV)
Latest News
Resources Shares
Obscure ASX mining share surges 29% following OZ Minerals copper deal update
Mergers & Acquisitions
Boom! Here's why the Havilah Resources share price just exploded 165%
Resources Shares
Oz Minerals share price rallies on potential $200m acquisition
Share Market News
UBS forecasts cobalt price to climb 60% over 18 months
HAV ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
---|---|---|---|---|---|
YesNo |
About Havilah Resources Ltd
Havilah Resources Ltd is a mineral exploration and development company. The company explores Gold, copper, cobalt, and other base metals. It is engaged in exploring its projects in South Australia. The company holds interests in the Kalkaroo copper-gold-molybdenum project, Mutooroo copper-cobalt-gold project, Maldorky iron ore project, Grants iron ore project, and Prospect Hill tin project. Kalkaroo is undeveloped open pit copper deposit in Australia on a CuEq Ore Reserve basis. The Mutooroo is a lode-style massive sulphide copper-cobalt deposit located about 60 km southwest of Broken Hill. The Grants iron ore project lies 8 km south of the Barrier Highway and the Transcontinental Railway, and one hour drive southwest of Broken Hill.
HAV Share Price History Data provided by Morningstar.
Date | Close | Change | % Change | Volume | Open | High | Low |
---|---|---|---|---|---|---|---|
20 Dec 2024 | $0.21 | $0.00 | 0.00% | 122,305 | $0.22 | $0.22 | $0.21 |
19 Dec 2024 | $0.21 | $-0.02 | -8.79% | 170,567 | $0.23 | $0.23 | $0.21 |
18 Dec 2024 | $0.23 | $0.01 | 4.55% | 10,001 | $0.23 | $0.23 | $0.23 |
17 Dec 2024 | $0.22 | $-0.01 | -4.44% | 140,689 | $0.23 | $0.23 | $0.21 |
16 Dec 2024 | $0.23 | $-0.01 | -4.35% | 242,307 | $0.24 | $0.24 | $0.23 |
13 Dec 2024 | $0.23 | $0.00 | 0.00% | 1,083,084 | $0.24 | $0.25 | $0.23 |
12 Dec 2024 | $0.24 | $0.00 | 0.00% | 2,133 | $0.24 | $0.24 | $0.24 |
11 Dec 2024 | $0.23 | $-0.01 | -4.17% | 276,290 | $0.24 | $0.24 | $0.23 |
10 Dec 2024 | $0.24 | $0.01 | 4.26% | 303,704 | $0.24 | $0.24 | $0.23 |
09 Dec 2024 | $0.24 | $0.00 | 0.00% | 50,933 | $0.24 | $0.24 | $0.24 |
06 Dec 2024 | $0.24 | $0.00 | 0.00% | 465,446 | $0.22 | $0.24 | $0.22 |
05 Dec 2024 | $0.23 | $0.00 | 0.00% | 372,743 | $0.23 | $0.24 | $0.23 |
04 Dec 2024 | $0.24 | $0.03 | 14.29% | 414,189 | $0.21 | $0.24 | $0.21 |
03 Dec 2024 | $0.21 | $0.01 | 5.00% | 417,225 | $0.20 | $0.21 | $0.20 |
02 Dec 2024 | $0.20 | $0.00 | 0.00% | 264,146 | $0.20 | $0.20 | $0.20 |
29 Nov 2024 | $0.20 | $0.01 | 5.19% | 227,892 | $0.20 | $0.20 | $0.20 |
28 Nov 2024 | $0.19 | $0.00 | 0.00% | 106,089 | $0.19 | $0.20 | $0.19 |
27 Nov 2024 | $0.19 | $-0.01 | -5.13% | 443,200 | $0.19 | $0.19 | $0.19 |
26 Nov 2024 | $0.20 | $-0.01 | -5.00% | 129,539 | $0.20 | $0.20 | $0.20 |
25 Nov 2024 | $0.20 | $0.01 | 5.13% | 49,237 | $0.20 | $0.20 | $0.20 |
22 Nov 2024 | $0.20 | $0.00 | 0.00% | 2,857 | $0.20 | $0.20 | $0.20 |
21 Nov 2024 | $0.20 | $0.00 | 0.00% | 45,243 | $0.20 | $0.21 | $0.20 |
Director Transactions Data provided by Morningstar.
Date | Director | Type | Amount | Value | Notes |
---|---|---|---|---|---|
20 Sep 2024 | Simon Gray | Issued | 14,202 | $2,556 |
Rights issue.
|
20 Sep 2024 | Victor Previn | Issued | 175,119 | $31,521 |
Rights issue.
|
20 Sep 2024 | Christopher Giles | Issued | 138,888 | $25,000 |
Rights issue.
|
Directors & Management Data provided by Morningstar.
Name | Title | Start Date | Profile |
---|---|---|---|
Mr Victor Previn | Non-Executive Director | Oct 2019 |
Mr Previn is one of the original founders of Nova Eye Medical Limited. It is listed on the ASX as EYE. His career spans more than 40 years in both the ophthalmic laser industry and the wider ophthalmic device sector. Victor was responsible for developing and commercialising the technology platform that is now the core of Nova Eye Medical Limited's current production. He has spent more than 3 decades in the ophthalmic laser industry travelling widely throughout Asia, Europe and the USA in a business development capacity. Victor is a long-term shareholder of Havilah and resides in Adelaide. He is Chair of Risk Committee.
|
Dr Christopher William Giles | Executive Director- Technical | Nov 2013 |
Dr Giles is an internationally experienced exploration geologist having been directly involved in exploration programs resulting in the discovery of several operating gold mines in various parts of the world, including Indonesia, Tanzania, and the Tanami and the Eastern Goldfields regions of Australia. Chris was a founding member of Havilah Resources Limited and has played a key role in the strategic accumulation of the Group's mineral tenement holding in the Curnamona Province region of northeastern South Australia. As the Technical Director for Havilah Resources Limited, Chris has been responsible for ground selection and overseeing exploration programs contributing to the delineation of 8 new mineral resources within this tenement area, resulting in the Group's present JORC Mineral Resource inventory. He is member of Risk Committee.
|
Mr Simon Ramsey Alexander Gray | Company SecretaryExecutive ChairmanExecutive Director | Jan 2019 |
Mr Gray has over 35 years of experience as a Chartered Accountant including 20 years as a partner with Grant Thornton, a national accounting firm. During his last 5 years at the firm, he was responsible for the Grant Thornton Mining and Energy group. Simon retired from active practice during July 2015. His key expertise lies in audit and risk, valuations, due diligence and ASX listings. Simon currently serves as the Company Secretary of Nova Eye Medical Limited (ASX: EYE), Company Secretary and Chief Financial Officer of Vintage Energy Ltd (ASX: VEN), and is a Director of several unlisted companies. He is member of Risk Committee.
|
Top Shareholders Data provided by Morningstar.
Name | Shares | Capital |
---|---|---|
BNP Paribas Noms Pty Ltd | 46,449,519 | 13.69% |
Maptek Pty Ltd | 20,961,621 | 6.18% |
IQ EQ (Jersey) Limted <The Ayscough 2 A/C> | 19,301,188 | 5.69% |
Trindal Pty Ltd <The Wilpena A/C> | 17,457,718 | 5.15% |
Trindal Pty Ltd | 11,212,806 | 3.31% |
Glencore Australia Holdings Pty Ltd | 10,153,756 | 2.99% |
Trindal Pty Ltd <Trindal Super Fund A/C> | 9,804,834 | 2.89% |
Mr Paul George Clark | 8,200,000 | 2.42% |
Citicorp Nominees Pty Limited | 7,725,595 | 2.28% |
Woolsthorpe Investments Limited | 6,943,408 | 2.05% |
Miss Krystyna Helena Kasperowicz | 3,701,470 | 1.09% |
Statsmin Nominees Pty Ltd | 3,644,038 | 1.07% |
Trindal Pty Ltd <Trindal Super Fund A/C> i | 3,437,357 | 1.01% |
Statsmin Nominees Pty Ltd <Statsmin Super Fund A/C> | 2,836,363 | 0.84% |
HNC Holdings Pty Ltd | 2,654,411 | 0.78% |
Craig Park Pty Ltd | 2,363,669 | 0.70% |
Talager Pty Ltd | 2,172,904 | 0.64% |
Dianne Pearl Investments Pty Ltd <Dianne Pearl Family A/C> | 1,935,851 | 0.57% |
Treasury Services Group Pty Ltd <Nero Resource Fund A/C> | 1,881,808 | 0.55% |
Dr Keith Robert Johnson | 1,650,000 | 0.49% |